share_log

Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.26%)

Sorrento Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-The Vanguard Group(6.26%)

美股SEC公告 ·  2023/02/09 11:32
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息